Can ciliates cure cancer?
Können Wimperntierchen Krebs heilen? Jeder kennt sie vom Biologie-Unterricht, hat sie als Schüler schon einmal unter dem Mikroskop gesehen: Wimperntierchen, ähnlich wie Pantoffeltierchen, die in
Menu
Können Wimperntierchen Krebs heilen? Jeder kennt sie vom Biologie-Unterricht, hat sie als Schüler schon einmal unter dem Mikroskop gesehen: Wimperntierchen, ähnlich wie Pantoffeltierchen, die in
Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI Cilian AG, a biopharmaceutical company focused on the development of
Cilian publishes articles in the European Journal of Gastroenterology & Hepatology. “Leading journal presents in vitro studies for endogenous Ciliate lipases as therapeutic candidates for
European Journal of Gastroenterology & Hepatology “Leading journal presents in vitro studies for endogenous Ciliate lipases as therapeutic candidates for oral treatment of exocrine pancreatic
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity Antibody glycosylation is a key parameter in the optimization of antibody therapeutics.
Cilian AG Receives European Patent For Therapeutic Antibody Münster, Germany, July 2016: the European Patent Office granted Cilian a new patent claiming recombinant production of
Cilian provides update on veterinary vaccine program “Cilian has completed a number of in vivo efficacy studies on its sub-unit seasonal flu vaccine for human
Cilian AG announced that a patent for its MAb production technology have been issued by the European Patent Office “The European Patent Office granted Cilian
CILIAN AG reports positive in vivo results for its seasonal sub-unit flu vaccine, CiFlu®. “German based biotech company CILIAN AG reports positive in vivo results
CILIAN develops an innovative Influenza subunit vaccine together with European collaborative research programme ADITEC. “CILIAN AG is now an affiliated member of the European collaborative
Experts for viral vaccines, digestive enzymes and cancer immunotherapy monoclonal antibodies with the most modern production and development technology.
Johann-Krane-Weg 42
48149 Münster, Germany
phone: +49 251 6 20 31 -0
fax: +49 251 6 20 31 -16
e-mail: info@cilian.de